Christoffer Rosenblad
Förmögenhet: 2 M $ per 2026-05-31
Förmögenhet: 2 M $ per 2026-05-31
Christoffer Rosenblad is currently Chief Executive Officer at Xvivo Perfusion AB since 2022, Director at Bentley Endovascular Group AB, and Independent Director at Sedana Medical AB since 2020.
Formerly, Mr. Rosenblad worked as Controller at Ciba Vision Nordic AB. Education includes a graduate degree from Chalmers University of Technology and an MBA from Handelshögskolan i Göteborg.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
XVIVO PERFUSION AB 0,17 % | 2025-07-29 | 53 523 ( 0,17 % ) | 2 M $ | 2026-05-31 |
SEDANA MEDICAL AB 0,02 % | 2024-12-31 | 20 000 ( 0,02 % ) | 20 383 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| XVIVO PERFUSION AB | Verkställande Direktör | 2022-09-27 |
| SEDANA MEDICAL AB | Direktör/Styrelseledamot | 2020-05-19 |
| Företag | Position | Slut |
|---|---|---|
Ciba Vision Nordic AB | Comptroller/Controller/Revisor | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Handelshögskolan i Göteborg
Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ciba Vision Nordic AB | |
Xvivo Perfusion AB
Xvivo Perfusion AB Medical SpecialtiesHealth Technology Operates as a medical technology company which develops solutions for organ, tissue, and cell preservation | Health Technology |
Sedana Medical AB
Sedana Medical AB Medical SpecialtiesHealth Technology Develops and wholesales medical devices and drugs | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån